Skip to main content
Top
Published in:

09-05-2024 | Prediabetes | Review Article

RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes

Authors: Rakesh Sahay, Viswanathan Mohan, Sanjay Agarwal, Banshi Saboo, Sujoy Ghosh, L. Sreenivasa Murthy, Ambika Gopalakrishnan Unnikrishnan, Nitin Kapoor, Arvind Gupta, Sudhir Bhandari, Pratap Jethwani, Manoj Chawla, J. K. Sharma, Anshul Kumar, Shalini Jaggi, Rajeev Chawla, Vijay Viswanathan, B. M. Makkar

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2024

Login to get access

Abstract

The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the test was modified in the US to two sample test 0 and 120 min, i.e., fasting and 2 h after 75 g glucose and this has been in practice all over the world. Traditional diabetologists continue to measure some of the intermediate samples, particularly the 60 min or 1 h value which identifies individuals even before the fasting or 2 h value becomes abnormal. Thus, even before the stage of prediabetes when one has a normal fasting and 2 h value, a raised 1 h value above 155 mg/dl has been shown to predict who will progress to diabetes. A group of 22 international experts recently got together and the IDF Position Statement on the 1 h value was published which shows why the 1 h value in the OGTT should be reintroduced in the routine lab testing of OGTT. This article is an endorsement of the IDF Position Statement on the 1 h value. Introducing the 1 h value in the OGTT is particularly relevant to India which has one of the fastest conversions of prediabetes to diabetes and also a very rapid loss of beta cell function. Identifying early stages of intermediate hyperglycemia can help to prevent diabetes and also reverse the condition.
Literature
12.
15.
go back to reference Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759–63.PubMed Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759–63.PubMed
18.
go back to reference Mohan V, Goldhaber-Fiebert JD, Radha V, Gokulakrishnan K. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. Indian J Med Res. 2011;133:294–9.PubMedPubMedCentral Mohan V, Goldhaber-Fiebert JD, Radha V, Gokulakrishnan K. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. Indian J Med Res. 2011;133:294–9.PubMedPubMedCentral
28.
go back to reference Das S, Samal KC, Baliarsinha AK, Tripathy BB. Lean (underweight) NIDDM - peculiarities and differences in metabolic and hormonal status - a pilot study. J Assoc Physicians India. 1995;43:339–42.PubMed Das S, Samal KC, Baliarsinha AK, Tripathy BB. Lean (underweight) NIDDM - peculiarities and differences in metabolic and hormonal status - a pilot study. J Assoc Physicians India. 1995;43:339–42.PubMed
Metadata
Title
RSSDI endorses the IDF Position Statement on 1 h post load plasma glucose for diagnosis of intermediate hyperglycemia and type 2 diabetes
Authors
Rakesh Sahay
Viswanathan Mohan
Sanjay Agarwal
Banshi Saboo
Sujoy Ghosh
L. Sreenivasa Murthy
Ambika Gopalakrishnan Unnikrishnan
Nitin Kapoor
Arvind Gupta
Sudhir Bhandari
Pratap Jethwani
Manoj Chawla
J. K. Sharma
Anshul Kumar
Shalini Jaggi
Rajeev Chawla
Vijay Viswanathan
B. M. Makkar
Publication date
09-05-2024
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2024
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-024-01345-1

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more